Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUTE: Fluticasone (APT-1011) in Eosinophilic Esophagitis
2016-004749-10Phase 2Completed
- Sponsor
- Adare Pharma Solutions
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in eosinophilic esophagitis (EoE) comparing APT-1011 dose-ranging arm with Placebo arm (2 arms). Primary endpoint: Histological response at Week 12. Started Jul 2017; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on 2016-004749-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004749-10.